Why to choose metformin as first line treatment in type2 diabetes? the answer is simple!
Grimaldi, A.é
La Revue du Praticien 66(5): 475-476
2016
ISSN/ISBN: 2101-017X PMID: 30512562 Document Number: 687626
Document emailed within 1 workday
Related Documents
Boussageon, R.ém. 2016: Type 2 diabetes: metformin a first line. Where are the proofs]? La Revue du Praticien 66(4): 355-357Schneider, J. 1995: Is it correct that in type Ii diabetes, treatment with metformin should be discontinued starting at age 65? Der Internist 36(3): 301-302
Zhang, J.-p.; Yang, W.-y.; Hong, T.-p.; Yang, J.-k.; Xiao, W.-h.; Gao, H.-w.; Yang, Y. 2007: Efficacy and safety of extended-release metformin in treatment of type 2 diabetes mellitus Zhonghua Yi Xue Za Zhi 87(18): 1238-1240
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Mick, D.G.; Broniarczyk, S.M.; Haidt, J. 2004: Choose, Choose, Choose, Choose, Choose, Choose, Choose: Emerging and Prospective Research on the Deleterious Effects of Living in Consumer Hyperchoice Journal of Business Ethics 52(2): 207-211
Van Dijk, P.R.; Landman, G.W.D.; Bilo, H.J.G. 2012: Role of metformin in diabetes treatment--is metformin falling from grace? Nederlands Tijdschrift Voor Geneeskunde 156(43): A5297
Perusicová, J.; Cacáková, V.; Richtrová, A. 1996: The effect of metformin on lactate levels in type Ii diabetes Vnitrni Lekarstvi 42(11): 772-775
Kirk, J.K.; Pearce, K.A.; Michielutte, R.; Summerson, J.H. 1999: Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes? Journal of Family Practice 48(11): 879-882
Rosak, C.; Hövelmann, R.; Martin, J. 2003: Type 2 diabetes -- higher doses of metformin improve metabolic control MMW Fortschritte der Medizin 145(21): 39
Cox, S.L. 2004: Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes Drugs of Today 40(7): 633-643
Grant, P.J. 1998: Metformin reduces circulating factor VIi concentrations in patients with type 2 diabetes mellitus Thrombosis and Haemostasis 80(1): 209-210
Lavrenko, A.V.; Kutsenko, L.A.; Solokhina, I.L.; Rasin, M.S.; KaÄdashev, I.P. 2011: Efficacy of metformin as initial therapy in patients with coronary artery disease and diabetes type 2 Likars'ka Sprava 2011(1-2): 89-95